Ildong Pharmaceutical Private Limited
About Ildong Pharmaceutical Private Limited
Data last updated:
Ildong Pharmaceutical Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2020PTC053408. Its GSTIN is 23AAFCI8687P1ZP (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.25 Lakh. It is led by directors Mohd Shakeel Qureshi (Managing Director) and Ashish Sahu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhopal, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.93 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net loss of ₹41,245 (net margin -0.2%) and EBITDA of ₹2.49 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years.
The company has about 16 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressWard No 09, Near Old Unani Safa Khana, Bhopal, Madhya Pradesh, India – 462001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ildong Pharmaceutical Private Limited
The main business activity of Ildong Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ildong Pharmaceutical Private Limited FY 2025 filings available
Ildong Pharmaceutical Private Limited reported revenue of ₹1.93 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ildong Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 28% over three years, including 31% growth in the latest year. EBITDA fell 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ildong Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.49 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹41,245 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ildong Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ildong Pharmaceutical are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ildong Pharmaceutical Private Limited
Ildong Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Delysaa Healthcare Private Limited | ₹1.95 Cr (FY 2025) | •••• | •••• | 723.0% | •••• | Ahmedabad, Gujarat, India |
| Gromax Healthcare Private Limited | ₹1.95 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Chennai, Tamil Nadu, India |
| Satguru Distributors Private Limited | ₹1.94 Cr (FY 2024) | •••• | •••• | 76.0% | •••• | New Delhi, Delhi, India |
| Doshi Medical Service Private Limited | ₹1.94 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Ar Tradex Private Limited | ₹1.94 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Ildong Pharmaceutical Private Limited this company | ₹1.93 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Bhopal, Madhya Pradesh, India |
| Deccan Pharmact Private Limited | ₹1.93 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Bangalore, Karnataka, India |
| Medihealth Lifesciences ( India ) Private Limited | ₹1.93 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Jaipur, Rajasthan, India |
| Aquarius Health Care Private Limited | ₹1.93 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Muzaffarpur, Bihar, India |
| MNC Biotech Private Limited | ₹1.93 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Kanpur, Uttar Pradesh, India |
| New Medicon Pharma Lab Private Limited | ₹1.93 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Ildong Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Ildong Pharmaceutical Private Limited
Ildong Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Shakeel Qureshi | Managing Director | 22 Oct 2020 | 5 Years 11 Months | Current |
| Ashish Sahu | Director | 22 Oct 2020 | 5 Years 11 Months | Current |
Ownership and Shareholding of Ildong Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ildong Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Feb 2023 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Ildong Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Ildong Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ildong Pharmaceutical Private Limited
Ildong Pharmaceutical Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Aditya Sen ceased to be Additional Director on 15 Mar 2024.
Credit Ratings, Litigation & Regulatory Alerts for Ildong Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ildong Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ildong Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ildong Pharmaceutical Private Limited
Ildong Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAFCI8687P1ZP | Madhya Pradesh | Active | 05 Nov 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ildong Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ildong Pharmaceutical Private Limited
Ildong Pharmaceutical is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 October 2020 (6+ years old) and is registered under CIN U51909MP2020PTC053408.
Ildong Pharmaceutical reported revenue of ₹1.93 Cr for FY 2025 (up 31% YoY).
Ildong Pharmaceutical has 2 current directors:
- Mohd Shakeel Qureshi - Managing Director
- Ashish Sahu - Director
Ildong Pharmaceutical reported a net loss of ₹41,245 (net margin -0.2%) and EBITDA of ₹2.49 Lakh (EBITDA margin 1.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ildong Pharmaceutical is 28% over three years. In the latest year (FY 2025) revenue rose 31%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ildong Pharmaceutical is 23AAFCI8687P1ZP, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Ildong Pharmaceutical is U51909MP2020PTC053408. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ildong Pharmaceutical was incorporated on 22 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Ildong Pharmaceutical by revenue are Delysaa Healthcare Private Limited, Gromax Healthcare Private Limited, Satguru Distributors Private Limited, Doshi Medical Service Private Limited, Ar Tradex Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Aditya Sen ceased to be Additional Director on 15 Mar 2024. Nikhil Artwani ceased to be Additional Director on 15 Mar 2024. Mohd Shakeel Qureshi ceased to be Director on 20 Feb 2024. Ildong Pharmaceutical has 5 board changes on record in total.
The registered office of Ildong Pharmaceutical is at Ward No 09, Near Old Unani Safa Khana, Bhopal, Madhya Pradesh, India – 462001.